Health
Mixed results for arthritis drug repurposed as Covid-19 treatment – Yahoo News Australia
A trio of new studies published in JAMA Internal Medicine on Tuesday examining the efficacy of an arthritis drug against Covid-19 showed inconsistent results.
A trio of new studies published in JAMA Internal Medicine on Tuesday examining the efficacy of an arthritis drug against Covid-19 showed inconsistent results.
Tocilizumab has been used by doctors since the start of the pandemic with the hope of tamping down an abnormal immune response known as a “cytokine storm” that causes severe organ damage in some hospitalized Covid-19 patients.
Unlike steroids, which suppress the immune system more broadly, tocilizumab blocks a particular signaling protei…
-
General24 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News13 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News13 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
Business17 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025